{"id":760,"date":"2023-01-12T15:42:17","date_gmt":"2023-01-12T14:42:17","guid":{"rendered":"http:\/\/local.fabentech.fr\/la-technologie-danticorps-polyclonaux-de-fabentech-selectionnee-par-la-commission-europeenne-pour-lutter-contre-les-menaces-nrbc-dans-le-cadre-du-consortium-counteract\/"},"modified":"2023-06-29T11:14:54","modified_gmt":"2023-06-29T09:14:54","slug":"fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium","status":"publish","type":"post","link":"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/","title":{"rendered":"Fabentech\u2019s polyclonal antibody technology chosen by the European Commission to counter CBRN threats within the framework of the Counteract consortium"},"content":{"rendered":"<p>FABENTECH will receive a grant of 5 million euros to develop a first countermeasure against a first biological pathogen.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>FABENTECH will receive a grant of 5 million euros to develop a first countermeasure against a first biological pathogen.<\/p>\n","protected":false},"author":1,"featured_media":150,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-760","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Fabentech\u2019s polyclonal antibody technology chosen by the European Commission to counter CBRN threats within the framework of the Counteract consortium - Fabentech<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fabentech\u2019s polyclonal antibody technology chosen by the European Commission to counter CBRN threats within the framework of the Counteract consortium - Fabentech\" \/>\n<meta property=\"og:description\" content=\"FABENTECH will receive a grant of 5 million euros to develop a first countermeasure against a first biological pathogen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/\" \/>\n<meta property=\"og:site_name\" content=\"Fabentech\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-12T14:42:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-29T09:14:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fabentech.com\/wp-content\/uploads\/2023\/04\/news1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2021\" \/>\n\t<meta property=\"og:image:height\" content=\"1346\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"symediane\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"symediane\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/\",\"url\":\"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/\",\"name\":\"Fabentech\u2019s polyclonal antibody technology chosen by the European Commission to counter CBRN threats within the framework of the Counteract consortium - Fabentech\",\"isPartOf\":{\"@id\":\"https:\/\/www.fabentech.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fabentech.com\/wp-content\/uploads\/2023\/04\/news1.jpg\",\"datePublished\":\"2023-01-12T14:42:17+00:00\",\"dateModified\":\"2023-06-29T09:14:54+00:00\",\"author\":{\"@id\":\"https:\/\/www.fabentech.com\/en\/#\/schema\/person\/48a65a28ca6c5e879bd426fc5c853bc8\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/#primaryimage\",\"url\":\"https:\/\/www.fabentech.com\/wp-content\/uploads\/2023\/04\/news1.jpg\",\"contentUrl\":\"https:\/\/www.fabentech.com\/wp-content\/uploads\/2023\/04\/news1.jpg\",\"width\":2021,\"height\":1346},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.fabentech.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fabentech\u2019s polyclonal antibody technology chosen by the European Commission to counter CBRN threats within the framework of the Counteract consortium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fabentech.com\/en\/#website\",\"url\":\"https:\/\/www.fabentech.com\/en\/\",\"name\":\"Fabentech\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fabentech.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fabentech.com\/en\/#\/schema\/person\/48a65a28ca6c5e879bd426fc5c853bc8\",\"name\":\"symediane\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fabentech.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.fabentech.com\/wp-content\/litespeed\/avatar\/e73599470e2ea80bc1488aa06cfcca21.jpg?ver=1775009793\",\"contentUrl\":\"https:\/\/www.fabentech.com\/wp-content\/litespeed\/avatar\/e73599470e2ea80bc1488aa06cfcca21.jpg?ver=1775009793\",\"caption\":\"symediane\"},\"sameAs\":[\"http:\/\/local.fabentech.fr\"],\"url\":\"https:\/\/www.fabentech.com\/en\/author\/symediane\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fabentech\u2019s polyclonal antibody technology chosen by the European Commission to counter CBRN threats within the framework of the Counteract consortium - Fabentech","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/","og_locale":"en_US","og_type":"article","og_title":"Fabentech\u2019s polyclonal antibody technology chosen by the European Commission to counter CBRN threats within the framework of the Counteract consortium - Fabentech","og_description":"FABENTECH will receive a grant of 5 million euros to develop a first countermeasure against a first biological pathogen.","og_url":"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/","og_site_name":"Fabentech","article_published_time":"2023-01-12T14:42:17+00:00","article_modified_time":"2023-06-29T09:14:54+00:00","og_image":[{"width":2021,"height":1346,"url":"https:\/\/www.fabentech.com\/wp-content\/uploads\/2023\/04\/news1.jpg","type":"image\/jpeg"}],"author":"symediane","twitter_card":"summary_large_image","twitter_misc":{"Written by":"symediane","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/","url":"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/","name":"Fabentech\u2019s polyclonal antibody technology chosen by the European Commission to counter CBRN threats within the framework of the Counteract consortium - Fabentech","isPartOf":{"@id":"https:\/\/www.fabentech.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/#primaryimage"},"image":{"@id":"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fabentech.com\/wp-content\/uploads\/2023\/04\/news1.jpg","datePublished":"2023-01-12T14:42:17+00:00","dateModified":"2023-06-29T09:14:54+00:00","author":{"@id":"https:\/\/www.fabentech.com\/en\/#\/schema\/person\/48a65a28ca6c5e879bd426fc5c853bc8"},"breadcrumb":{"@id":"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/#primaryimage","url":"https:\/\/www.fabentech.com\/wp-content\/uploads\/2023\/04\/news1.jpg","contentUrl":"https:\/\/www.fabentech.com\/wp-content\/uploads\/2023\/04\/news1.jpg","width":2021,"height":1346},{"@type":"BreadcrumbList","@id":"https:\/\/www.fabentech.com\/en\/fabentechs-polyclonal-antibody-technology-chosen-by-the-european-commission-to-counter-cbrn-threats-within-the-framework-of-the-counteract-consortium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.fabentech.com\/en\/"},{"@type":"ListItem","position":2,"name":"Fabentech\u2019s polyclonal antibody technology chosen by the European Commission to counter CBRN threats within the framework of the Counteract consortium"}]},{"@type":"WebSite","@id":"https:\/\/www.fabentech.com\/en\/#website","url":"https:\/\/www.fabentech.com\/en\/","name":"Fabentech","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fabentech.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.fabentech.com\/en\/#\/schema\/person\/48a65a28ca6c5e879bd426fc5c853bc8","name":"symediane","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fabentech.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/www.fabentech.com\/wp-content\/litespeed\/avatar\/e73599470e2ea80bc1488aa06cfcca21.jpg?ver=1775009793","contentUrl":"https:\/\/www.fabentech.com\/wp-content\/litespeed\/avatar\/e73599470e2ea80bc1488aa06cfcca21.jpg?ver=1775009793","caption":"symediane"},"sameAs":["http:\/\/local.fabentech.fr"],"url":"https:\/\/www.fabentech.com\/en\/author\/symediane\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/posts\/760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/comments?post=760"}],"version-history":[{"count":7,"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/posts\/760\/revisions"}],"predecessor-version":[{"id":1025,"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/posts\/760\/revisions\/1025"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/media\/150"}],"wp:attachment":[{"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/media?parent=760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/categories?post=760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fabentech.com\/en\/wp-json\/wp\/v2\/tags?post=760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}